Moderators and speakers of the 9th AMR Conference
Adam Johnson
Senior Microbiologist, Centauri Therapeutics
Akhil Bansal
Founder, AMR Funding Circle & Policy Fellow, Center for Global Development
Alasdair MacGowan
Consultant in Infection Research, North Bristol NHS Trust
Aleksandar Danilovski
Founder and Managing Partner, DALISCO d.o.o.
Alexander Krause
Director Global Market Access, bioMérieux SA
Alexandra Cameron
Senior Expert, Unit Head A.I. Impact Initiatives and Research Coordination, AMR Division, World Health Organization
Andreas Diacon
Chief Scientific Officer, TASK
Anouk Muller
Consultant Clinical Microbiologist, Haaglanden Medical Centre
Astrid Pentz-Murr
Scientific Affairs Senior Manager, GARDP
Becky McCall
PhD candidate, University College London
Caline Mattar
Associate Professor of Medicine, Washington University
Christoph Dehio
Full Professor of Molecular Microbiology, Director of National Centre of Competence in Research (NCCR) “AntiResist”
Francesca Chiara
Chair, The AMR Narrative
Glenn E. Dale
Chief Development Officer, BioVersys AG
Herbert Wetli
Head of Pharmaceutical Development, GARDP
Ingrid Wanninger
Managing Director, HYpharm GmbH
Jasper Claessen
Team coordinator – Policies for Research and Availability of Medicines, Dutch Ministry of Health
Jens Hellwage
Managing Director, InfectoGnostics Research Campus Jena
Kate Grailey
Behavioural Research Lead, Fleming Initiative
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
Leander Grode
Managing Director, Serum Life Science Europe GmbH
Marc Gitzinger
CEO, BioVersys AG & President, BEAM Alliance
Markus Zeitlinger
Professor, Specialist in Internal Medicine and Clinical Pharmacology, Medical University of Vienna
Olga Tosas Auguet
Epidemiologist, World Health Organization
Peter Beyer
Deputy Executive Director, GARDP Foundation
Pol Vandenbroucke
VP Global Government Affairs, Shionogi Inc.
Radu Botgros
Senior Scientific Officer, European Medicines Agency
Remko van Leeuwen
CEO, SurvivX
Richard Grohs
Scientist, Leibniz Institute of Photonic Technology
Rienk Pypstra
Chief Medical Officer & Head of Infectious Diseases, tranScrip
Robert Skov
President, ESCMID & Senior Consultant, Statens Serum Institut
Rolf Müller
Managing Director, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Sarah Tschudin Sutter
Head Division of Infectious Diseases, University Hospital Basel
Sebastian Hiller
Professor for Structural Biology and Biophysics at Biozentrum, University of Basel
Sibyl Anthierens
Professor, University of Antwerp
Taslimarif Saiyed
CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP)
Tobi Nagel
Founder and President, Phages for Global Health
Usman Nakakana
Senior Program Officer Vaccine Development and Impact, Gates Foundation
Wolfgang Philipp
Acting Deputy Head HERA, European Commission
Yuping Li
Assistant Professor, University of Basel